Cherington Charles, a ten percent owner, bought Ernexa Therapeutics Inc. ($ERNAW) shares on the open market four times in the last year, totaling $4.6 million. His most recent purchase occurred on February 10, 2026. These buys rank 186th among 4,983 individual insiders, surpassing the average purchase of $1.5 million across 3.29 transactions. Charles reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 10, 2026 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Warrants to Purchase Common Stock | 4000000 | $0.00 | 4,000,000.0000 | 7,848,889 | 9999.99% | 50.96% |
| Feb. 10, 2026 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Common Stock | 4000000 | $0.50 | 6,779,440.0000 | 7,848,889 | 143.91% | 50.96% |
| June 9, 2025 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Common Stock | 21241163 | $0.10 | 41,659,743.0000 | 52,244,929 | 104.03% | 40.66% |
| Sept. 24, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Common Stock | 261756 | $0.00 | 818,221.0000 | 0 | 47.04% | 0.00% |
| Sept. 24, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | S | Warrants (right to buy) | 523512 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 24, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Common Stock | 1237762 | $0.00 | 6,824,766.0000 | 0 | 22.15% | 0.00% |
| Sept. 24, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Common Stock | 5420823 | $0.00 | 12,245,589.0000 | 0 | 79.43% | 0.00% |
| Sept. 24, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Common Stock | 1562988 | $0.00 | 13,808,577.0000 | 0 | 12.76% | 0.00% |
| Sept. 24, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | S | 12.0% Senior Convertible Notes due December 12, 2028 | 3000000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 24, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | S | 6.0% Senior Convertible Promissory Notes due 2028 | 3540000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 24, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Common Stock | 4768783 | $0.00 | 5,587,004.0000 | 0 | 582.82% | 0.00% |
| Sept. 24, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | S | Warrants (right to buy) | 3125976 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 24, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | S | Warrants (right to buy) | 2475524 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 2, 2025 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Common Stock | 3768397 | $0.10 | 20,401,602.0000 | 52,244,929 | 22.66% | 7.21% |
| Oct. 29, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | S | Warrants (right to buy) | 3125976 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 29, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | S | 6.0% Senior Convertible Promissory Notes due 2028 | 3540000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 29, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | S | Warrants (right to buy) | 523512 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 29, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | S | Warrants (right to buy) | 2475524 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 29, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Common Stock | 261756 | $0.00 | 818,221.0000 | 0 | 47.04% | 0.00% |
| Oct. 29, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Common Stock | 4768783 | $0.00 | 5,587,004.0000 | 0 | 582.82% | 0.00% |
| Oct. 29, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Common Stock | 1237762 | $0.00 | 6,824,766.0000 | 0 | 22.15% | 0.00% |
| Oct. 29, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Common Stock | 5420823 | $0.00 | 12,245,589.0000 | 0 | 79.43% | 0.00% |
| Oct. 29, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Common Stock | 1562988 | $0.00 | 13,808,577.0000 | 0 | 12.76% | 0.00% |
| Oct. 29, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | C | Common Stock | 2819546 | $0.50 | 16,628,123.0000 | 0 | 20.42% | 0.00% |
| Sept. 23, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | 6.0% Senior Convertible Promissory Notes due 2028 | 120000 | $0.00 | 3,420,000.0000 | 0 | 3.64% | 0.00% |
| Sept. 23, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Warrants (right to buy) | 83916 | $0.00 | 2,391,608.0000 | 0 | 3.64% | 0.00% |
| Sept. 23, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | 6.0% Senior Convertible Promissory Notes due 2028 | 120000 | $0.00 | 3,540,000.0000 | 0 | 3.51% | 0.00% |
| Sept. 23, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | Warrants (right to buy) | 83916 | $0.00 | 2,475,524.0000 | 0 | 3.51% | 0.00% |
| Sept. 24, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | P | 12.0% Senior Convertible Notes due September 24, 2025 | 1368626 | $1368626.00 | 1,368,626.0000 | 0 | 9999.99% | 0.00% |
| Oct. 29, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | C | 12.0% Senior Convertible Notes due September 24, 2025 | 1368626 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 29, 2024 | Ernexa Therapeutics Inc. | $ERNA | Cherington Charles | TenPercentOwner | S | 12.0% Senior Convertible Notes due December 12, 2028 | 3000000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 27, 2023 | Comera Life Sciences Holdings, Inc. | $CMRA | Cherington Charles | TenPercentOwner | P | Series A Convertible Perpetual Preferred Stock | 3896 | $500000.00 | 3,895.5300 | 23,113,051 | 9999.99% | 0.02% |
| Dec. 29, 2023 | Comera Life Sciences Holdings, Inc. | $CMRA | Cherington Charles | TenPercentOwner | P | Warrants to Purchase Common Stock | 20650908 | $0.00 | 20,650,908.0000 | 23,113,051 | 9999.99% | 89.35% |
| Dec. 29, 2023 | Comera Life Sciences Holdings, Inc. | $CMRA | Cherington Charles | TenPercentOwner | P | 12.0% Senior Secured Convertible Notes | 567900 | $567900.00 | 567,900.0000 | 23,113,051 | 9999.99% | 2.46% |